During the past decade, Krankenhaus Saarlouis vom DRK conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Saarlouis vom DRK" #1 collaborator was "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Saarlouis vom DRK" are "Breast Neoplasms" (1 trials), "Ovarian Cancer" (1 trials), "Quality of Life" (1 trials) and "Recurrent Ovarian Carcinoma" (1 trials). Many other conditions were trialed in "Krankenhaus Saarlouis vom DRK" in a lesser frequency.

Most popular intervention types in "Krankenhaus Saarlouis vom DRK" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Palbociclib + endocrine therapy" (1 trials) and "Trabectidin (Yondelis)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Saarlouis vom DRK" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenhaus Saarlouis vom DRK". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Krankenhaus Saarlouis vom DRK, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Saarlouis vom DRK, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".